These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 12028603)
21. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease. Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212 [TBL] [Abstract][Full Text] [Related]
23. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice. Fishkind D; Paris BE; Aronow WS J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330 [TBL] [Abstract][Full Text] [Related]
24. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention. Talbert RL J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609 [TBL] [Abstract][Full Text] [Related]
25. [Dilated myocarditis and cardiomyopathies. The dysimmune hypothesis]. Sachs RN Arch Mal Coeur Vaiss; 1990 Mar; 83(3):407-11. PubMed ID: 2108636 [TBL] [Abstract][Full Text] [Related]
26. [Acute myocarditis in children. Study of 11 clinical cases]. Varé D; Varé B; Dauphin C; Lafeuille H; Gaulme J; Labbé A; Motreff P; Lusson JR Arch Mal Coeur Vaiss; 2000 May; 93(5):571-9. PubMed ID: 10858855 [TBL] [Abstract][Full Text] [Related]
27. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy--a critical analysis]. Schultheiss HP Z Kardiol; 1989 Jun; 78(6):349-59. PubMed ID: 2667264 [TBL] [Abstract][Full Text] [Related]
28. Treatment of chronic myocarditis with corticosteroids. Kühl U; Schultheiss HP Eur Heart J; 1995 Dec; 16 Suppl O():168-72. PubMed ID: 8682089 [TBL] [Abstract][Full Text] [Related]
29. [Immunosuppressive therapy of myocarditis?]. Schultheiss HP; Kühl U; Janda I; Schanwell M; Strauer BE Herz; 1992 Apr; 17(2):112-21. PubMed ID: 1577363 [TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive and immunomodulatory treatment for myocarditis. Maisch B; Herzum M; Hufnagel G; Schonian U Curr Opin Cardiol; 1996 May; 11(3):310-24. PubMed ID: 8835874 [TBL] [Abstract][Full Text] [Related]
31. Lessons learned from experimental myocarditis. Matsumori A Herz; 2012 Dec; 37(8):817-21. PubMed ID: 23092967 [TBL] [Abstract][Full Text] [Related]
32. Treatment of experimental myocarditis via modulation of the renin-angiotensin system. Daniels MD; Hyland KV; Engman DM Curr Pharm Des; 2007; 13(13):1299-305. PubMed ID: 17506715 [TBL] [Abstract][Full Text] [Related]
33. Predictors of outcome in patients with suspected myocarditis. Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053 [TBL] [Abstract][Full Text] [Related]
34. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis. Nasser N; Perles Z; Rein AJJT; Nir A Pediatr Cardiol; 2006; 27(1):87-90. PubMed ID: 16132296 [TBL] [Abstract][Full Text] [Related]
36. Treatment of heart failure in infants and children. Clark BJ Heart Dis; 2000; 2(5):354-61. PubMed ID: 11728282 [TBL] [Abstract][Full Text] [Related]
37. [Myocarditis in childhood: results of a decade's research]. Schmaltz AA; Kandolf R Klin Padiatr; 2001; 213(1):1-7. PubMed ID: 11225467 [TBL] [Abstract][Full Text] [Related]
38. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW; Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013 [TBL] [Abstract][Full Text] [Related]
39. Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress. Sukumaran V; Watanabe K; Veeraveedu PT; Ma M; Gurusamy N; Rajavel V; Suzuki K; Yamaguchi K; Kodama M; Aizawa Y Eur J Pharmacol; 2011 Feb; 652(1-3):126-35. PubMed ID: 21115000 [TBL] [Abstract][Full Text] [Related]